Warning: The NCBI web site requires JavaScript to function. more...
Effects on osteoclast and osteoblast activities in cultured mouse calvarial bones by synovial fluids from patients with a loose joint prosthesis and from osteoarthritis patients.
Andersson MK, Lundberg P, Ohlin A, Perry MJ, Lie A, Stark A, Lerner UH.
Arthritis Res Ther. 2007;9(1):R18.
Related citations
Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.
Palmqvist P, Lundberg P, Persson E, Johansson A, Lundgren I, Lie A, Conaway HH, Lerner UH.
J Biol Chem. 2006 Feb 3;281(5):2414-29. Epub 2005 Oct 25.
IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
Palmqvist P, Persson E, Conaway HH, Lerner UH.
J Immunol. 2002 Sep 15;169(6):3353-62.
The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.
Kwan Tat S, Pelletier JP, Lajeunesse D, Fahmi H, Lavigne M, Martel-Pelletier J.
Clin Exp Rheumatol. 2008 Mar-Apr;26(2):295-304.
Synovial fluid macrophages are capable of osteoclast formation and resorption.
Adamopoulos IE, Sabokbar A, Wordsworth BP, Carr A, Ferguson DJ, Athanasou NA.
J Pathol. 2006 Jan;208(1):35-43.
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.
J Bone Miner Res. 2005 Sep;20(9):1659-68. Epub 2005 May 2.
Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.
Bone. 1999 Nov;25(5):517-23.
Stimulation of resorption in cultured mouse calvarial bones by thiazolidinediones.
Schwab AM, Granholm S, Persson E, Wilkes B, Lerner UH, Conaway HH.
Endocrinology. 2005 Oct;146(10):4349-61. Epub 2005 Jun 30.
Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones.
Swanson C, Lorentzon M, Conaway HH, Lerner UH.
Endocrinology. 2006 Jul;147(7):3613-22. Epub 2006 Apr 13.
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.
J Bone Miner Res. 2000 Aug;15(8):1459-66.
Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones.
Ahlen J, Andersson S, Mukohyama H, Roth C, Bäckman A, Conaway HH, Lerner UH.
Bone. 2002 Jul;31(1):242-51.
Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
Sabokbar A, Kudo O, Athanasou NA.
J Orthop Res. 2003 Jan;21(1):73-80.
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, Shinki T, Gillespie MT, Martin TJ, Higashio K, Suda T.
Endocrinology. 2000 Sep;141(9):3478-84.
Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.
J Bone Miner Res. 2004 Nov;19(11):1873-81. Epub 2004 Aug 16.
Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes.
Kim YG, Lee CK, Oh JS, Kim SH, Kim KA, Yoo B.
Arthritis Rheum. 2010 Feb;62(2):515-23.
Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
Neale SD, Sabokbar A, Howie DW, Murray DW, Athanasou NA.
J Orthop Res. 1999 Sep;17(5):686-94.
Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts.
Bi Y, Nielsen KL, Kilts TM, Yoon A, A Karsdal M, Wimer HF, Greenfield EM, Heegaard AM, Young MF.
Bone. 2006 Jun;38(6):778-86. Epub 2005 Dec 20.
Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
Adamopoulos IE, Wordsworth PB, Edwards JR, Ferguson DJ, Athanasou NA.
Hum Pathol. 2006 Sep;37(9):1176-85. Epub 2006 Jul 18.
Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin.
Crotti TN, Smith MD, Findlay DM, Zreiqat H, Ahern MJ, Weedon H, Hatzinikolous G, Capone M, Holding C, Haynes DR.
Biomaterials. 2004 Feb;25(4):565-73.
Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
Ishida M, Amano S.
J Bone Miner Metab. 2004;22(5):415-29.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on